Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Hoogtepunten in kaart vanaf gecombineerd IHC/EHF-congres
sep 2021 | Hoofdpijn